Why the study?
Which risk factors should be determined in which individuals at which time for thrombophilia in women on hormonal therapy, during pregnancy, and in children?
Which risk factors should be determined in which individuals at which time for thrombophilia in women on hormonal therapy, during pregnancy, and in children?
This consensus report provides expert guidelines on testing for thrombophilia in women on hormonal therapy, during pregnancy, and in pediatric populations.
No takes yet. Share an insight, caveat, or question.
Guides selective thrombophilia testing in women on OCs, during pregnancy, and in children; extends expert consensus to standardize risk assessment.
Brenner et al. (2002) conducted a review in Thrombophilia. Diagnostic testing for thrombophilia was evaluated on Consensus guidelines for testing for thrombophilic states. A consensus of 26 experts established general guidelines for testing for thrombophilic states in women using oral contraceptives, during pregnancy, and in neonates and children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: